Company Overview - GeneDx reported over 30% growth in volume and revenue for the year 2025, achieving $427 million in revenue while maintaining over 70% gross margins, indicating a profitable operation [2][3] - The company aims to continue its growth trajectory into 2026, focusing on serving an increasing number of patients and families with high-quality care [3] Leadership Presentation - The presentation was introduced by Abbey Stanley from JPMorgan Healthcare Investment Banking, with CEO Katherine Stueland leading the discussion, followed by a Q&A session with CFO Kevin Feeley and COO Bryan Dechairo [1] - The leadership emphasized the importance of their mission in pediatric care, highlighting a specific case to illustrate the impact of their services [3][4]